Home LiteratureArticle Details
PMID: 10933057 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Neoplasia (New York, N.Y.) ·Vol. 1 ·No. 5 ·1999-11-00 ·Pages 424-30

Murakami K, Sakukawa R, Ikeda T, Matsuura T, Hasumura S, Nagamori S, Yamada Y, Saiki I

Abstract

Intrahepatic metastasis is one of the malignant features of hepatocellular carcinoma (HCC). Matrix metalloproteinases (MMPs) and urokinase-type plasminogen activator (u-PA)/plasmin, are known to be associated with the invasive properties of various types of tumor cells. In this study, we examined which proteinases play a role in the metastatic invasion of human HCC cell lines. JHH-5 and JHH-6 cells constitutively expressed mRNAs for both membrane-type 1 matrix metalloproteinase (MT1-MMP) and u-PA and invaded through reconstituted MATRIGEL in vitro, whereas JHH-7 cells expressed u-PA mRNA but not MT1-MMP and did not invade. However, hepatocyte growth factor (HGF) induced MT1-MMP expression on the surface of JHH-7 cells and markedly increased invasiveness of JHH-7 in a concentration-dependent manner. Moreover, cleavage activity for pro-MMP-2 was induced in HGF-treated JHH-7 cells. MMP inhibitor, rather than serine proteinase inhibitor, potently inhibited HCC cell invasion. Intrahepatic injection of HCC cell lines into athymic nude mice caused visible intrahepatic metastases in vivo. Moreover, JHH-7 tumors showed expression of MT1-MMP mRNA, while in vitro cultured JHH-7 cells did not. These findings suggest that MT1-MMP plays an important role in the invasive properties of HCC cells, and that HGF modifies the invasive properties of noninvasive HCC cells.

MeSH Terms
Animals Carcinoma, Hepatocellular/pathology Collagen/metabolism Dose-Response Relationship, Drug Drug Combinations Female Hepatocyte Growth Factor/biosynthesis Humans Laminin/metabolism Liver/pathology Liver Neoplasms/pathology Matrix Metalloproteinase 14 Matrix Metalloproteinase 2/metabolism Matrix Metalloproteinases, Membrane-Associated Metalloendopeptidases/antagonists & inhibitors,biosynthesis,physiology Mice Mice, Nude Neoplasm Invasiveness Neoplasm Transplantation Organ Size Protease Inhibitors/pharmacology Proteoglycans/metabolism Recombinant Proteins/metabolism Reverse Transcriptase Polymerase Chain Reaction Time Factors Tumor Cells, Cultured Urokinase-Type Plasminogen Activator/biosynthesis
Chemicals
Drug Combinations Laminin Mmp14 protein, mouse Protease Inhibitors Proteoglycans Recombinant Proteins matrigel Hepatocyte Growth Factor Collagen Urokinase-Type Plasminogen Activator Matrix Metalloproteinases, Membrane-Associated Metalloendopeptidases Matrix Metalloproteinase 2 Matrix Metalloproteinase 14
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Murakami K
Department of Pathogenic Biochemistry, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Japan.
Sakukawa R
Ikeda T
Matsuura T
Hasumura S
Nagamori S
Yamada Y
Saiki I
References (41)
41 references, click to expand
  1. The human urokinase-plasminogen activator gene and its promoter.
    Nucleic Acids Res. 1985 Apr 25;13(8):2759-71 PMID: 2987867
  2. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Crit Rev Biotechnol. 1988;8(2):131-48 PMID: 2976309
  3. Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines.
    Hepatogastroenterology. 1990 Oct;37(5):457-60 PMID: 1701409
  4. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.
    Science. 1991 Feb 15;251(4995):802-4 PMID: 1846706
  5. Growth factors in the regulation of plasminogen-plasmin system in tumor cells.
    Semin Thromb Hemost. 1991 Jul;17(3):231-9 PMID: 1839081
  6. Hepatocyte growth factor concentrations after liver resection.
    Lancet. 1992 Mar 28;339(8796):818 PMID: 1347849
  7. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
    J Immunol. 1992 Jun 1;148(11):3636-42 PMID: 1316922
  8. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species.
    Exp Cell Res. 1992 Oct;202(2):423-31 PMID: 1327854
  9. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.
    J Cell Biol. 1992 Nov;119(3):629-41 PMID: 1383237
  10. Biology and biochemistry of proteinases in tumor invasion.
    Physiol Rev. 1993 Jan;73(1):161-95 PMID: 8419965
  11. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
    Diagn Mol Pathol. 1993 Jun;2(2):74-80 PMID: 8269280
  12. Tumor cell interactions with the extracellular matrix during invasion and metastasis.
    Annu Rev Cell Biol. 1993;9:541-73 PMID: 8280471
  13. A matrix metalloproteinase expressed on the surface of invasive tumour cells.
    Nature. 1994 Jul 7;370(6484):61-5 PMID: 8015608
  14. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan.
    Cancer. 1994 Nov 15;74(10):2772-80 PMID: 7954236
  15. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases.
    Hepatology. 1995 Dec;22(6):1728-34 PMID: 7489981
  16. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Cancer Res. 1996 Jan 15;56(2):384-92 PMID: 8542596
  17. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential.
    Hepatology. 1996 Aug;24(2):316-22 PMID: 8690399
  18. Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas.
    J Cell Biochem. 1996 Sep 15;62(4):443-53 PMID: 8891890
  19. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hepatology. 1996 Nov;24(5):1058-62 PMID: 8903375
  20. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
    Cell Growth Differ. 1996 Nov;7(11):1513-23 PMID: 8930401
  21. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel.
    Clin Exp Metastasis. 1996 Nov;14(6):520-9 PMID: 8970582
  22. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma.
    Hepatology. 1997 Jan;25(1):87-92 PMID: 8985270
  23. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells.
    Cancer Gene Ther. 1996 Nov-Dec;3(6):393-404 PMID: 8988842
  24. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
    J Biol Chem. 1997 Jan 24;272(4):2446-51 PMID: 8999957
  25. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Hepatology. 1997 Apr;25(4):862-6 PMID: 9096589
  26. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
    Gastroenterology. 1997 Apr;112(4):1290-6 PMID: 9098015
  27. A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors.
    Biol Pharm Bull. 1997 Apr;20(4):345-8 PMID: 9145207
  28. Results of 90 consecutive hepatectomies for hepatocellular carcinoma: a multivariate analysis of survival.
    Semin Oncol. 1997 Apr;24(2 Suppl 6):S6-1-6 PMID: 9151909
  29. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells.
    Oncol Res. 1996;8(12):503-11 PMID: 9160354
  30. The urokinase-type plasminogen activator system in cancer metastasis: a review.
    Int J Cancer. 1997 Jul 3;72(1):1-22 PMID: 9212216
  31. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Cancer Res. 1997 Aug 1;57(15):3305-13 PMID: 9242465
  32. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study.
    Jpn J Clin Oncol. 1997 Aug;27(4):251-7 PMID: 9379514
  33. Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines.
    Int J Oncol. 1998 Mar;12(3):655-9 PMID: 9472107
  34. Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro.
    Clin Exp Metastasis. 1998 Jan;16(1):74-82 PMID: 9502079
  35. Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.
    J Hepatol. 1998 Feb;28(2):231-9 PMID: 9514536
  36. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
    J Med Chem. 1998 Apr 9;41(8):1209-17 PMID: 9548812
  37. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    Cancer Res. 1998 May 15;58(10):2234-9 PMID: 9605771
  38. Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor.
    Int J Urol. 1998 May;5(3):276-81 PMID: 9624561
  39. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals.
    Clin Exp Metastasis. 1998 Oct;16(7):633-43 PMID: 9932610
  40. Marimastat (BB2516): current status of development.
    Cancer Chemother Pharmacol. 1999;43 Suppl:S56-60 PMID: 10357560
  41. Changing views of the role of matrix metalloproteinases in metastasis.
    J Natl Cancer Inst. 1997 Sep 3;89(17):1260-70 PMID: 9293916
Article Info
Journal
Neoplasia (New York, N.Y.)
Abbr.
Neoplasia
ISSN
1522-8002
Published
1999-11-00
Pages
424-30
Language
English
Region
United States
NLM ID
100886622
PMCID
PMC1508115
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com